By growing intact strawberry cells in stable, climate-free environments, the company ensures a reliable, standardized supply of bioactives.
Human trials show rapid, lasting benefits, marking a major step for bio-based ingredients in the nutraceutical sector.
The acquisition strengthens Azelis’s presence in Spain and enhances its nutraceutical offerings across Europe.
The new Jakarta facility will provide formulation, testing, pilot production and technical training for food and beverage manufacturers across Indonesia and Southeast Asia.